Monitor for any conversion to a 13D or increase in stake above 10%, which would signal a shift from passive to active intent. The small float and insider-related nature of this filing suggest limited trading catalyst.
Price Chart
Executive Summary
Advance On Ventures Ltd and its director Chen Yi Lee filed a Schedule 13G disclosing a combined 7.5% beneficial ownership stake in Advanced Biomed Inc. (ADVB), consisting of 123,840 shares. The filing is passive (Rule 13d-1(d)) with no intent to influence control. This is a new filing from this entity, though a prior 13G from Pau Hung To (a separate filer) was filed 33 days ago. The stake is modest in size and the investor is a small BVI company with a Taiwan-based individual, suggesting a personal or insider-related holding rather than an institutional accumulation signal.
Key Financial Metrics
Key Facts
- Advance On Ventures Ltd and Chen Yi Lee filed a joint Schedule 13G disclosing beneficial ownership of 123,840 shares of Advanced Biomed Inc. common stock.
- The stake represents 7.5% of the 1,652,133 shares outstanding as of May 29, 2026.
- Advance On Ventures Ltd holds 109,200 shares (6.6%); Chen Yi Lee directly holds 14,640 shares.
- The filing is made under Rule 13d-1(d) (passive investor, no control intent).
- This is a new filing from this reporting group; a separate 13G from Pau Hung To was filed on August 20, 2026.
Financial Impact
No financial impact; passive stake disclosure with no material change in operations or capital structure.
Risk Factors
- Low liquidity and small market cap of ADVB could amplify any future insider selling or dilution events.
- The filing does not disclose any intent to engage with management, but the presence of a director as a reporting person indicates insider alignment.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0002155122-26-000001 |
| Document: 0002155122-26-000001-index-headers.html | 0002155122-26-000001 |
| Document: 0002155122-26-000001-index.html | 0002155122-26-000001 |
| Document: 0002155122-26-000001.txt | 0002155122-26-000001 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | SC 13G | $6.38 | awaiting T+60 | — | $3.17 (−50.31%) |
Jul 17, 2026 14w ago | 8-K | $8.90 $5.16 | ▼ −42.02% | ▼ −46.86% | $3.17 (−64.38%) |
Jun 30, 2026 16w ago | 8-K | $4.84 $6.31 | ▼ −30.37% | ▼ −27.50% | $3.17 (+34.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers